Yahoo
TSXV - Delayed Quote CAD

MedX Health Corp (MDX.V)

0.0400 0.0000 (0.00%)
At close: October 29 at 2:36:22 PM EDT
Chart Range Bar
Loading chart for MDX.V
  • Previous Close 0.0400
  • Open 0.0400
  • Bid 0.0400 x --
  • Ask 0.0450 x --
  • Day's Range 0.0400 - 0.0400
  • 52 Week Range 0.0400 - 0.0700
  • Volume 5,000
  • Avg. Volume 53,827
  • Market Cap (intraday) 13.117M
  • Beta (5Y Monthly) 1.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date (est.) Dec 1, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It also provides DermSecure, a telemedicine software application. In addition, the company offers MedX rehab console system, rehab portable laser, and home unit; OraLase, a dental PBM laser; and veterinary-specific lasers. MedX Health Corp was incorporated in 1999 and is headquartered in Mississauga, Canada.

www.medxhealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MDX.V
33.33%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

MDX.V
33.33%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

MDX.V
42.86%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

MDX.V
63.64%
S&P/TSX Composite index (^GSPTSE)
69.32%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -361.91%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    569.79k

  • Net Income Avi to Common (ttm)

    -6.19M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.59k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.46M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: